Showing 1 - 10 of 43
important and R&D-intensive industries: Semiconductors and Pharmaceuticals. I employ two measures of a firm's R&D performance … size in Pharmaceuticals, but there is no relationship between patent quality and firm size in Semiconductors. Citations …
Persistent link: https://www.econbiz.de/10011807210
hazard. Focusing on pharmaceuticals consumption, this paper examines theoretically whether reference pricing, requiring …
Persistent link: https://www.econbiz.de/10011019119
Should governments allow parallel trade of pharmaceuticals? There is no clear-cut answer to this question, since …
Persistent link: https://www.econbiz.de/10005016228
Given the cost of trade and availability of pharmaceuticals, the driving force for parallel trade is the price … availability of pharmaceuticals for parallel trade should increase price competition in the destination country. Using 2003 …
Persistent link: https://www.econbiz.de/10010818749
We study effects of direct-to-consumer advertising (DTCA) in a market with two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients varying in their susceptability to medication are a priori uninformed of available medication. Physicians making the prescription...
Persistent link: https://www.econbiz.de/10008914353
-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel …
Persistent link: https://www.econbiz.de/10008918545
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced, if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10008918559
We analyse how a patent-holding (incumbent) firm may strategically use advertising ex ante to a¤ect the R&D investments in new (di¤eren- tiated) products, and thus the ex post market structure in the industry. We derive exact conditions for advertising and R&D being substitute strategies for...
Persistent link: https://www.econbiz.de/10008918562
New Zealand is acknowledged widely as the first country to implement a formal monetary policy agreement specifying an explicit inflation target. This agreement, signed in March 1990 between the Minister of Finance and the Governor of the Bank, was implemented under Section 9 of the Reserve Bank...
Persistent link: https://www.econbiz.de/10010932895
In March 2009, Business and Economic Research Limited ("BERL") published “Costs of Harmful Alcohol and Other Drug Use,” a report jointly commissioned by the Ministry of Health and ACC. BERL was asked to measure the costs of drug and alcohol abuse to New Zealand society, but not to evaluate...
Persistent link: https://www.econbiz.de/10005016213